Table 2.
Case | Age | Sex | Diagnosis | Postmortem acylcarnitine analysis | Fat staining |
---|---|---|---|---|---|
1 | 0 d | F | Unknown | None specific change | Negative |
2 | 0 d | M | Unknown | None specific change | Negative |
3 | 2 d | M | Pneumonia | Not analyzed | Negative |
4 | 22 d | M | Unknown | None specific change | Negative |
5 | 2 m | M | Acute respiratory infection | Not analyzed | Negative |
6 | 3 m | M | SIDS | None specific change | Negative |
7 | 4 m | M | SIDS | None specific change | Moderate |
8 | 5 m | M | Pneumonia | Not analyzed | Negative |
9 | 5 m | M | Unknown | Not analyzed | Negative |
10 | 7 m | M | SIDS | Not analyzed | Negative |
11 | 8 m | M | Reye's-like syndrome | Not analyzed | Moderate |
12 | 8 m | M | SIDS | Not analyzed | Negative |
13 | 10 m | F | Unknown | None specific change | Moderate |
14 | 11 m | F | Acute encephalopathy | Not analyzed | Negative |
15 | 11 m | F | Reye's-like syndrome | Long-chain fatty acid defect | Distinctive |
SIDS; sudden infant death syndrome, d; day, m; month, M; male, F; female.